title: Clinical significance of conduction disturbances after aortic valve intervention: current evidence.
abstract: The occurrence of new conduction abnormalities that lead to the requirement for new permanent pacemaker implantation (PPI) has been reported to be the most frequent complication following transcatheter aortic valve implantation (TAVI). However, the reasons and clinical significance of TAVI-induced conduction disturbances and PPI are yet to be fully delineated. This review aims to evaluate the procedure- and patient-related factors that may contribute to the development of aberrant atrioventricular conduction following TAVI as well as its clinical consequences.
authors.affiliation: Cardiology Department, Hospital General Universitario Gregorio Marañón and Universidad Europea de Madrid, Madrid, Spain, mmselles@secardiologia.es.
authors.forename: Manuel
authors.initials: M
authors.lastname: Martinez-Selles
authors.forename: Peter
authors.initials: P
authors.lastname: Bramlage
authors.forename: Martin
authors.initials: M
authors.lastname: Thoenes
authors.forename: Gerhard
authors.initials: G
authors.lastname: Schymik
mesh_terms: D001021:Aortic Valve / Q000503:physiopathology; D001024:Aortic Valve Stenosis / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D001145:Arrhythmias, Cardiac / Q000175:diagnosis / Q000191:economics / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D006328:Cardiac Catheterization / Q000009:adverse effects* / Q000379:methods; D002304:Cardiac Pacing, Artificial / Q000191:economics; D003362:Cost-Benefit Analysis; D017048:Health Care Costs; D006329:Heart Conduction System / Q000503:physiopathology*; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects* / Q000379:methods; D006801:Humans; D010138:Pacemaker, Artificial / Q000191:economics; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome